Results 181 to 190 of about 85,856,906 (279)

Yeast Knockout Strain Collection: Driving Functional Genomics, Biotechnological Applications and Human Disease Research

open access: yesYeast, EarlyView.
ABSTRACT The knockout strain collection of Saccharomyces cerevisiae has served as a valuable resource for functional genomics and yeast‐based biotechnology studies. A comprehensive single‐gene knockout strain collection, covering nearly all non‐essential genes, together with complementary mutant collections for essential genes, including temperature ...
Takashi Hirasawa
wiley   +1 more source

NADPH Oxidase 4 is Not Involved in Hypoxia‐Induced Pulmonary Hypertension [PDF]

open access: yesPulmonary Circulation, 2016
C, Veith   +8 more
openaire   +2 more sources

Dataset for 'Characterising NADPH oxidase in marine diatoms'

open access: yes
Dataset associated with the University of Southampton Doctoral Thesis 'Characterising NADPH oxidase in marine diatoms'.
Wheeler, Glen L.   +3 more
core   +1 more source

Mepolizumab Modifies Blood Eosinophil Proteome and Transcriptome in Severe Eosinophilic Asthma

open access: yesAllergy, EarlyView.
This study investigates the effect of mepolizumab on the proteomic and transcriptomic profile of blood eosinophils in SEA patients. Mepolizumab reduces the migratory capacity and effector‐related molecular signatures of circulating eosinophils in SEA patients.
Pablo Miguéns‐Suárez   +14 more
wiley   +1 more source

NADPH oxidase-4 promotes eccentric cardiac hypertrophy in response to volume overload. [PDF]

open access: yesCardiovasc Res, 2021
Schnelle M   +12 more
europepmc   +1 more source

Umbilical Cord Blood–Derived Extracellular Vesicles Enhance Neurovascular Regeneration and Improve Erectile Function in a Mouse Model of Bilateral Cavernous Nerve Injury

open access: yesAndrology, EarlyView.
ABSTRACT Background Erectile dysfunction (ED) secondary to cavernous nerve injury (CNI), such as that occurring after radical prostatectomy, remains a significant clinical challenge, particularly among patients who do not respond to phosphodiesterase Type 5 inhibitors (PDE5i).
Minh Nhat Vo   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy